ICLIT improved the overall efficacy more quickly
TSS
At 3 month of treatment, TSS in ICLIT group and SCIT group was 9.4 (1.7) and 12.5 (2.0), separately. Change of TSS in ICLIT group was 2.9 (1.2) with a decreased rate of 22.7% and change of TSS in SCIT group was 0.3 (0.5) with a decreased rate of 2.2%. ICLIT group showed significant degree of symptom improvement compared with SCIT group (p < 0.0001) (